Clinical Trials Browser

Phase 1/2 × Solid Tumor, Adult × Cetuximab × Clear all

NCT04585035 2025-03-18

Study to Evaluate D-1553 in Subjects With Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasmThoracic

Solid Tumor, Adult